.Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AB08_Etodolac.Etodolac .Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonStero.M01AB08_Etodolac.Etodolac| name: | Etodolac |
| ATC code: | M01AB08 | route: | oral |
| n-compartments | 2 |
Etodolac is a nonsteroidal anti-inflammatory drug (NSAID) used for the management of mild to moderate pain, osteoarthritis, and rheumatoid arthritis. It is commonly administered orally and is approved for medical use in many countries.
Pharmacokinetic parameters reported for healthy adult volunteers after a single 200 mg oral dose.
Boni, J, et al., & Cooper, S (1999). Pharmacokinetic and pharmacodynamic action of etodolac in patients after oral surgery. Journal of clinical pharmacology 39(7) 729–737. DOI:10.1177/00912709922008254 PUBMED:https://pubmed.ncbi.nlm.nih.gov/10392328
Brater, DC, & Lasseter, KC (1989). Profile of etodolac: pharmacokinetic evaluation in special populations. Clinical rheumatology 8 Suppl 1 25–35. DOI:10.1007/BF02214107 PUBMED:https://pubmed.ncbi.nlm.nih.gov/2525981
Benet, LZ (1994). Pharmacokinetic profile of etodolac in special populations. European journal of rheumatology and inflammation 14(1) 15–18. PUBMED:https://pubmed.ncbi.nlm.nih.gov/7744123